Bridge financing closed for 4D Lifetec AG
As one of the first investment projects, anfass Life Technologies AG took over the activities of 4D Lifetec AG in 2014 and has been actively supporting it ever since. The Swiss start-up has successfully developed a new technology for the early detection of cancer from blood samples (Liquid Biopsy).
Over the past 4 years, 4D Lifetec AG has developed a technology that can measure genetic instability in blood cells with high precision. The method has been successfully standardized with external partners. A further round of investments has now been initiated for the clinical validation of the test procedure and interim financing has been secured by anfass Life Technologies. www.4dlifetec.com